Cargando…
Emerging roles of purinergic signaling in anti-cancer therapy resistance
Cancer is a complex disease with a rapid growing incidence and often characterized by a poor prognosis. Although impressive advances have been made in cancer treatments, resistance to therapy remains a critical obstacle for the improvement of patients outcome. Current treatment approaches as chemo-,...
Autores principales: | Zanoni, Michele, Pegoraro, Anna, Adinolfi, Elena, De Marchi, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527280/ https://www.ncbi.nlm.nih.gov/pubmed/36200041 http://dx.doi.org/10.3389/fcell.2022.1006384 |
Ejemplares similares
-
P2X7 Receptor in Hematological Malignancies
por: De Marchi, Elena, et al.
Publicado: (2021) -
A2A Receptor Contributes to Tumor Progression in P2X7 Null Mice
por: De Marchi, Elena, et al.
Publicado: (2022) -
Editorial: Therapy resistance in tumor microenvironment: metabolic reprogramming and purinergic signaling
por: Zanoni, Michele, et al.
Publicado: (2023) -
Potentiating Cancer Immune Therapy via Nanomaterials and Purinergic Signaling
por: Ferrari, Davide, et al.
Publicado: (2022) -
The Role of Notch, Hedgehog, and Wnt Signaling Pathways in the Resistance of Tumors to Anticancer Therapies
por: Kumar, Vivek, et al.
Publicado: (2021)